Conference of WoundHSI 2019 SUDOSCAN presentation

Share on facebook
Share on twitter
Share on linkedin
Visuel article Sudoscan Oncology

SUDOSCAN IN DIABETES:
IDENTIFICATION AND FOLLOW-UP OF
THE AT RISK DIABETIC FOOT

Banner evenement WoundHSI June 2019

The role of quantitative sudomotor testing

Impeto Medical will present SUDOSCAN and the role of quantitative sudomotor testing during the 17th annual conference of WoundHSI, Wound Healing: Science & Industry, on 20-21 June 2019 at New York.

The diabetic foot is a very costly complication of diabetes both personally and financially. Pathophysiology often involves a combination of neuropathy and peripheral artery disease, progressing to ulceration and limb loss.  Current recommendations for foot screening detect the risk of diabetic complication too late in its course, and studies show poor compliance by the physicians in following guidelines.

Sudomotor nerves are unmyelinated autonomic fibers innervating sweat glands and affected early in diabetic neuropathy.  New sudomotor testing methods are rapid, quantitative, and reproducible; they may detect a diabetic foot at risk early, and can be implemented for routine clinical screening and accurate follow-up with minimal impact to the clinic’s work flow. Clinical research data on sudomotor function testing for the diabetic foot will be presented.

Impeto Medical

Impeto Medical

About Impeto Medical

Impeto Medical has developed a patented technology that assesses sudomotor function quickly and non-invasively. The results are a conductance, which expresses the health of the small nerve fibers innervating the sweat glands. The ease-of-use, quantitative, reproducible and sensitive results encourage its use to detect and follow the evolution of small fiber neuropathy.

Recent Posts

Subscribe to receive our scientific news

Name(Required)
Consent(Required)

Website dedicated
to health professionals

I am a health professional

To receive our latest scientific news:

Scroll to Top